SVWAG
ABBV icon

Sound View Wealth Advisors Group’s AbbVie ABBV Stock Holding History

Sound View Wealth Advisors Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Buy
58,534
+5,455
+10% +$1.17M 0.91% 30
2026
Q1 		$11.5M Buy
53,079
+290
+0.5% +$64.3K 0.79% 33
2025
Q4 		$12.1M Sell
52,789
-640
-1% -$146K 0.81% 31
2025
Q3 		$12.4M Sell
53,429
-1,506
-3% -$307K 0.85% 33
2025
Q2 		$10.2M Buy
54,935
+82
+0.1% +$15.2K 0.75% 34
2025
Q1 		$11.5M Sell
54,853
-3,959
-7% -$770K 0.94% 27
2024
Q4 		$10.5M Buy
58,812
+1,436
+3% +$264K 0.84% 32
2024
Q3 		$11.3M Buy
57,376
+3,352
+6% +$626K 0.92% 28
2024
Q2 		$9.27M Sell
54,024
-218
-0.4% -$36.1K 0.96% 28
2024
Q1 		$9.88M Sell
54,242
-2,415
-4% -$416K 1.05% 25
2023
Q4 		$8.78M Buy
56,657
+459
+0.8% +$66.9K 0.97% 25
2023
Q3 		$8.38M Buy
56,198
+2,320
+4% +$341K 1.04% 25
2023
Q2 		$7.26M Buy
53,878
+766
+1% +$112K 0.95% 28
2023
Q1 		$8.46M Sell
53,112
-3,545
-6% -$542K 1.16% 18
2022
Q4 		$8.78M Buy
56,657
+15,208
+37% +$2.33M 0.97% 25
2022
Q3 		$5.56M Sell
41,449
-374
-0.9% -$53.7K 1.25% 19
2022
Q2 		$6.41M Buy
41,823
+469
+1% +$71.7K 1.34% 18
2022
Q1 		$6.7M Sell
41,354
-780
-2% -$113K 1.27% 19
2021
Q4 		$5.71M Buy
42,134
+277
+0.7% +$32.7K 1.08% 23
2021
Q3 		$4.51M Sell
41,857
-2,161
-5% -$247K 0.94% 32
2021
Q2 		$4.96M Sell
44,018
-601
-1% -$67.7K 1.04% 26
2021
Q1 		$4.83M Sell
44,619
-89
-0.2% -$9.52K 1.12% 23
2020
Q4 		$4.79M Buy
44,708
+37
+0.1% +$3.56K 1.17% 23
2020
Q3 		$3.91M Sell
44,671
-318
-0.7% -$29.9K 1.03% 27
2020
Q2 		$4.42M Sell
44,989
-254
-0.6% -$22.4K 1.24% 21
2020
Q1 		$3.45M Buy
45,243
+1,700
+4% +$145K 1.19% 24
2019
Q4 		$3.85M Sell
43,543
-139
-0.3% -$11.5K 1.09% 28
2019
Q3 		$3.31M Buy
43,682
+12,673
+41% +$869K 0.99% 32
2019
Q2 		$2.25M Buy
+31,009
New +$2.44M 0.67% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sound View Wealth Advisors Group's ABBV Position: Q2 2026 in Review

Sound View Wealth Advisors Group increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $1.17M and bringing the position to 58,534 shares worth $14.7M. The position accounts for 0.91% of the portfolio, ranked #30.

Sound View Wealth Advisors Group first reported a position in ABBV in Q2 2019 and has held it in 29 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sound View Wealth Advisors Group held 58,534 shares of AbbVie worth $14.7M as of Q2 2026.
  • Sound View Wealth Advisors Group bought 5,455 AbbVie shares in Q2 2026, an estimated $1.17M.
  • AbbVie made up 0.91% of Sound View Wealth Advisors Group's portfolio in Q2 2026, its #30 holding.
  • Sound View Wealth Advisors Group first reported a position in AbbVie in Q2 2019 and has held it in 29 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sound View Wealth Advisors Group's 13F filing for Q2 2026, filed 11 Aug 2026.